Lakefront Biotherapeutics Stock Performance
as on October 12, 2026 at 2:15 pm IST
Day's Low
Day's High
$29.33$29.91
1.35%
Downside
0.61%
Upside
52 Week's Low
52 Week's High
100.00%
Downside
-100.00%
Upside
Lakefront Biotherapeutics share price movements today
- Previous Close
- $29.51
- Open
- $29.43
- Volume
- 218.7K
- Market Cap
- $1.9B
- Day's Low - High
- $29.33 - $29.91
Lakefront Biotherapeutics Historical Returns
- 1 Month Return
- + 10.89 %
- 3 Month Return
- -1.78 %
- 1 Year Return
- 0 %
- 3 Year Return
- 0 %
- 5 Year Return
- 0 %
Lakefront Biotherapeutics Stock Fundamentals & Key Indicators
Check Lakefront Biotherapeutics market cap, PE, PB, PEG ratios, dividend yield, and other key fundamental indicators.
Market Cap
$1.9B
EPS (TTM)
9.046
Dividend Yield
0.00%
Quarterly Earnings Growth YOY
0.00%
PE Ratio (TTM)
2.93
Industry PE ratio
-9.22
PEG Ratio
0.02
EBITDA
536.4M
Revenue (TTM)
990.6M
Profit Margin
94.88%
Return On Equity TTM
19.58%
Lakefront Biotherapeutics vs Peer Comparison
Compare market cap, revenue, PE, and other key metrics of Lakefront Biotherapeutics with its industry peers.
Company | Analyst View | Market Cap | 5 Years Return % | PE Ratio | Profit Margin % | Dividend Yield % |
|---|---|---|---|---|---|---|
| Buy | $1.9B | NA | 2.93 | 94.88% | 0.00% | |
| Neutral | $89.8B | -27.68% | -28.20 | -12.57% | 0.00% | |
| StrongBuy | $129.3B | 183.05% | 29.45 | 86.04% | 0.00% | |
| Buy | $76.9B | 37.12% | 17.83 | 84.86% | 0.50% |
Analyst Recommendation on Lakefront Biotherapeutics Stock
Based on 1 analysts
100.00%
Buy
0.00%
Hold
0.00%
Sell
Based on 1 analysts, 100% of analysts recommend a 'BUY' rating for Lakefront Biotherapeutics. Average target price of $45
Lakefront Biotherapeutics Share Price Target
Get share price movements and forecasts by analysts on Lakefront Biotherapeutics.
Current Price
$29.73
Analyzed by
1 Analysts
High
$45
Low
$45
Lakefront Biotherapeutics target price $0, a slight upside of 0% compared to current price of $29.73. According to 1 analysts rating.
Indian Investors' Interest in Lakefront Biotherapeutics Stock
Search interest for Lakefront Biotherapeutics Stock has increased by 109% in the last 30 days, reflecting an upward trend in search activity.
Time period: to
Change:109% versus previous 30 day period
Lakefront Biotherapeutics Quarterly Profit & Loss
All numbers in Millions USD
Lakefront Biotherapeutics Annual Profit & Loss
All numbers in Millions USD
Lakefront Biotherapeutics Quarterly Cash Flow
All numbers in Millions USD
Lakefront Biotherapeutics Annual Cash Flow
All numbers in Millions USD
Insights on Lakefront Biotherapeutics
Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.
POSITIVE IMPACTRevenue Rich
Revenue is up for the last 2 quarters, 6.48M → 12.11M (in $), with an average increase of 46.5% per quarter
- POSITIVE IMPACT
Price Rise
In the last 1 month, LKFT stock has moved up by 10.9%
NO EFFECTAgainst Peers
In the last 1 year, Moderna, Inc. Common Stock has given 738.6% return, outperforming this stock by 751.4%
- NO EFFECT
Against Peers
In the last 3 years, Moderna, Inc. Common Stock has given 123.3% return, outperforming this stock by 138.5%
NEGATIVE IMPACTProfit Down
Netprofit is down for the last 3 quarters, 782.14M → 2.10M (in $), with an average decrease of 91.8% per quarter
About Lakefront Biotherapeutics
| Organisation | Lakefront Biotherapeutics |
| Headquarters | SchaliEnhoevedreef 20 T, Mechelen, 2800, BE |
| Industry | Biotechnology |
| CEO | Henry O. Gosebruch |
Key Management of Lakefront Biotherapeutics
Name | Title |
|---|---|
Mr. Henry O. Gosebruch | CEO & Executive Director |
Ms. Christina Carlson J.D. | Chief Operating Officer |
Dr. Glenn Schulman M.P.H., Pharm. D., Pharm.D. | Head of Investor Relations |
Mr. Fred W. Blakeslee II | Executive VP & General Counsel |
Marieke Vermeersch | Head of Corporate Communication |
Ms. Tania Philipp | Chief People Officer |
Ms. Ellen Van Der Aar | Head of Development |
Dr. Jeevan Shetty | Head of Clinical Development Oncology |
Mr. Aaron L. Cox | Chief Financial Officer |
Ruiz Astigarraga | Head of Manufacturing Cell Therapy |
FAQs
What is Lakefront Biotherapeutics share price today?
Lakefront Biotherapeutics share price today is $29.73 as on at the close of the market. Lakefront Biotherapeutics share today touched a day high of $29.91 and a low of $29.33.
What is the 52 week high and 52 week low for Lakefront Biotherapeutics share?
Lakefront Biotherapeutics share touched a 52 week high of $0.00 on and a 52 week low of $0.00 on . Lakefront Biotherapeutics stock price today i.e. is closed at $29.73,which is -Infinity% down from its 52 week high and Infinity% up from its 52 week low.
What is Lakefront Biotherapeutics's market capitalisation today?
Lakefront Biotherapeutics market capitalisation is $0.00T as on .
How to invest in Lakefront Biotherapeutics Stock (LKFT) from India?
- Step 1: Open a free US stocks account on INDmoney App and transfer your Rupees into Dollars to your INDmoney US stocks account. For a step by step instruction, check How to Transfer Money to Your US Stocks Account .
- Step 2: Search for Lakefront Biotherapeutics on INDmoney app. Click on Buy button.
What is the minimum amount required to buy Lakefront Biotherapeutics Stock (LKFT) from India?
Indian investors can start investing in Lakefront Biotherapeutics (LKFT) shares with as little as ₹95.76000213623047 or $1 (as of ) using the INDmoney app.
For example: If you want to invest $10 or ₹957.60 in Lakefront Biotherapeutics stock (as per the Rupee-Dollar exchange rate as on ).
Based on Lakefront Biotherapeutics share’s latest price of $29.73 as on October 12, 2026 at 8:45 am IST, you will get 0.3364 shares of Lakefront Biotherapeutics. Learn more about
fractional shares .